Cargando…
Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching
BACKGROUND: An essential component of evaluating potential modified risk tobacco products is to determine how consumers use the product and resulting effects on biomarkers of toxicant exposure. STUDY DESIGN: Cigarette smokers (n=391) recruited in Minnesota and Oregon were randomised to either snus o...
Autores principales: | Hatsukami, Dorothy K, Severson, Herbert, Anderson, Amanda, Vogel, Rachael Isaksson, Jensen, Joni, Broadbent, Berry, Murphy, Sharon E, Carmella, Steven, Hecht, Stephen S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785094/ https://www.ncbi.nlm.nih.gov/pubmed/25991608 http://dx.doi.org/10.1136/tobaccocontrol-2014-052080 |
Ejemplares similares
-
Is low-nicotine Marlboro snus really snus?
por: Foulds, Jonathan, et al.
Publicado: (2008) -
Harm perception among Swedish daily smokers regarding nicotine, NRT-products and Swedish Snus
por: Wikmans, Tom, et al.
Publicado: (2010) -
Strong preference for mint snus flavor among research participants
por: Schneller, Liane M., et al.
Publicado: (2017) -
How do Smokers in a Snus-Prevalent Society Consider E-cigarettes, Snus, and Nicotine Replacement Therapy Products as Relevant Replacements for Cigarettes in the Event They Should Stop Smoking?
por: Vedøy, Tord Finne, et al.
Publicado: (2023) -
Longitudinal stability in cigarette smokers of urinary biomarkers of exposure to the toxicants acrylonitrile and acrolein
por: Chen, Menglan, et al.
Publicado: (2019)